Evolution of treatment targets in Crohn's disease

被引:4
作者
White, Jonathan R. [1 ,2 ,3 ]
Jairath, Vipul [4 ,5 ]
Moran, Gordon W. [1 ,2 ,3 ]
机构
[1] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England
[2] Univ Nottingham, Nottingham, England
[3] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[4] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
关键词
Crohn's disease; Treatment targets; Patient reported outcomes; Clinician reported activity indices; Biomarkers; Endoscopy; Imaging; Histology; INFLAMMATORY-BOWEL-DISEASE; PATIENT-REPORTED OUTCOMES; C-REACTIVE PROTEIN; POST-HOC ANALYSIS; QUALITY-OF-LIFE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; ACTIVITY INDEX; LEMANN INDEX; MAINTENANCE THERAPY;
D O I
10.1016/j.bpg.2019.02.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease is a chronic relapsing and remitting inflammatory disorder of the gastrointestinal tract, associated with significantly morbidity due to both symptoms and complications that have a considerable detrimental impact on a patient's quality of life. An early treat to target approach with disease modifying agents has been shown to significantly improve long term outcomes, demonstrated by a number of therapeutic targets in a number of modalities. This review will outline the current treatment targets and measures of disease burden in Crohn's disease. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数:9
相关论文
共 105 条
  • [1] Allez M, 2002, AM J GASTROENTEROL, V97, P947
  • [2] Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound
    Astegiano, M
    Bresso, F
    Cammarota, T
    Sarno, A
    Robotti, D
    Demarchi, B
    Sostegni, R
    Macchiarella, V
    Pera, A
    Rizzetto, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (08) : 927 - 931
  • [3] Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
    Baars, Judith E.
    Nuij, Veerle J. A. A.
    Oldenburg, Bas
    Kuipers, Ernst J.
    van der Woude, Christien J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (09) : 1634 - 1640
  • [4] Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
    Baert, Filip
    Moortgat, Liesbeth
    Van Assche, Gert
    Caenepeel, Philip
    Vergauwe, Philippe
    De Vos, Martine
    Stokkers, Pieter
    Hommes, Daniel
    Rutgeerts, Paul
    Vermeire, Severine
    D'Haens, Geert
    [J]. GASTROENTEROLOGY, 2010, 138 (02) : 463 - 468
  • [5] Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
    Beigel, Florian
    Deml, Matthias
    Schnitzler, Fabian
    Breiteneicher, Simone
    Goeke, Burkhard
    Ochsenkuehn, Thomas
    Brand, Stephan
    [J]. PLOS ONE, 2014, 9 (06):
  • [6] BEST WR, 1979, GASTROENTEROLOGY, V77, P843
  • [7] BEST WR, 1976, GASTROENTEROLOGY, V70, P439
  • [8] Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
    Bouguen, Guillaume
    Levesque, Barrett G.
    Feagan, Brian G.
    Kavanaugh, Arthur
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    Hanauer, Stephen B.
    Sandborn, William J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1042 - +
  • [9] Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease
    Bruining, David H.
    Loftus, Edward V., Jr.
    Ehman, Eric C.
    Siddiki, Hassan A.
    Nguyen, Douglas L.
    Fidler, Jeff L.
    Huprich, James E.
    Mandrekar, Jayawant N.
    Harmsen, William S.
    Sandborn, William J.
    Fletcher, Joel G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (08) : 679 - U90
  • [10] Do Not Assume Symptoms Indicate Failure of Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Bruining, David H.
    Sandborn, William J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 395 - 399